Top 10 Companies in Canada Life Sciences Industry: IT Spending Predictor 2009

Introduction

This databook provides insight into the top 10 companies in Canada life sciences industry in terms of their estimated IT spend.

Report Highlights
Highlights

The top 10 companies in Canada life sciences industry in terms of estimated IT spending spent the largest portion of their IT budgets on hardware, a segment that accounted for about 28% of the IT budgets among these firms. This was followed by spending on software and services.

Among the top 10 companies, a major portion of IT spending is allocated to internal IT. External services include product vendors, local resellers, telcos, systems integrators and specialist outsourcers. Internal IT alone accounted for approximately 38% of the total estimated IT spending by these companies.
[Studien Infos ausblenden]

TABLE OF CONTENTS
OVERVIEW 1
Catalyst 1
Summary 1
INTRODUCTION 9
Reasons to Purchase 9
Definitions 10
CANADA LIFE SCIENCES INDUSTRY: ESTIMATED SPENDING ON IT 12
Overview 12
Estimated spending by technology segment 14
Estimated IT spending by channel 16
EXTENDICARE REIT 18
Budget overview 18
Extendicare REIT, estimated spending on IT 19
Extendicare REIT, estimated IT spending by channel 23
BIOVAIL CORP 25
Budget overview 25
Biovail Corp, estimated spending on IT 26
Biovail Corp, estimated IT spending by channel 30
MDS INC 32
Budget overview 32
MDS Inc, estimated spending on IT 33
MDS Inc, estimated IT spending by channel 37
NOVARTIS PHARMA CANADA INC 39
Budget overview 39
Novartis Pharma Canada Inc, estimated spending on IT 40
Novartis Pharma Canada Inc, estimated IT spending by channel 44
APOTEX INC 46
Budget overview 46
Apotex Inc, estimated spending on IT 47
Apotex Inc, estimated IT spending by channel 51
ANGIOTECH PHARMACEUTICALS INC 53
Budget overview 53
Angiotech Pharmaceuticals Inc, estimated spending on IT 54
Angiotech Pharmaceuticals Inc, estimated IT spending by channel 58
AXCAN PHARMA INC 60
Budget overview 60
Axcan Pharma Inc, estimated spending on IT 61
Axcan Pharma Inc, estimated IT spending by channel 65
ASPREVA PHARMACEUTICALS CORP 67
Budget overview 67
Aspreva Pharmaceuticals Corp, estimated spending on IT 68
Aspreva Pharmaceuticals Corp, estimated IT spending by channel 72
BAYER INC 74
Budget overview 74
Bayer Inc, estimated spending on IT 75
Bayer Inc, estimated IT spending by channel 79
PROFESSIONAL PHARMACY WHOLESALE SERVICES INC 81
Budget overview 81
Professional Pharmacy Wholesale Services Inc, estimated spending on IT 82
Professional Pharmacy Wholesale Services Inc, estimated IT spending by channel 86
APPENDIX 88
Methodology 88
Further reading 89
How to contact experts in your industry 89
Disclaimer 89
[Inhaltsverzeichnis ausblenden]

LIST OF FIGURES
Figure 1: Life sciences industry, Canada, spending on IT ($m), 2008 and 2009 12
Figure 2: Life sciences industry, Canada, estimated spending by IT segment ($m), 2008 14
Figure 3: Life sciences industry, Canada, estimated spending on IT by channel ($m), 2008 16
Figure 4: Extendicare REIT, estimated spending by IT segment, 2008 19
Figure 5: Extendicare REIT, estimated spending by IT sub-segment ($m), 2008 21
Figure 6: Extendicare REIT, estimated spending on IT by channel, 2008 23
Figure 7: Biovail Corp, estimated spending by IT segment, 2008 26
Figure 8: Biovail Corp, estimated spending by IT sub-segment ($m), 2008 28
Figure 9: Biovail Corp, estimated spending on IT by channel, 2008 30
Figure 10: MDS Inc, estimated spending by IT segment, 2008 33
Figure 11: MDS Inc, estimated spending by IT sub-segment ($m), 2008 35
Figure 12: MDS Inc, estimated spending on IT by channel, 2008 37
Figure 13: Novartis Pharma Canada Inc, estimated spending by IT segment, 2008 40
Figure 14: Novartis Pharma Canada Inc, estimated spending by IT sub-segment ($m), 2008 42
Figure 15: Novartis Pharma Canada Inc, estimated spending on IT by channel, 2008 44
Figure 16: Apotex Inc, estimated spending by IT segment, 2008 47
Figure 17: Apotex Inc, estimated spending by IT sub-segment ($m), 2008 49
Figure 18: Apotex Inc, estimated spending on IT by channel, 2008 51
Figure 19: Angiotech Pharmaceuticals Inc, estimated spending by IT segment, 2008 54
Figure 20: Angiotech Pharmaceuticals Inc, estimated spending by IT sub-segment ($m), 2008 56
Figure 21: Angiotech Pharmaceuticals Inc, estimated spending on IT by channel, 2008 58
Figure 22: Axcan Pharma Inc, estimated spending by IT segment, 2008 61
Figure 23: Axcan Pharma Inc, estimated spending by IT sub-segment ($m), 2008 63
Figure 24: Axcan Pharma Inc, estimated spending on IT by channel, 2008 65
Figure 25: Aspreva Pharmaceuticals Corp, estimated spending by IT segment, 2008 68
Figure 26: Aspreva Pharmaceuticals Corp, estimated spending by IT sub-segment ($m), 2008 70
Figure 27: Aspreva Pharmaceuticals Corp, estimated spending on IT by channel, 2008 72
Figure 28: Bayer Inc, estimated spending by IT segment, 2008 75
Figure 29: Bayer Inc, estimated spending by IT sub-segment ($m), 2008 77
Figure 30: Bayer Inc, estimated spending on IT by channel, 2008 79
Figure 31: Professional Pharmacy Wholesale Services Inc, estimated spending by IT segment, 2008 82
Figure 32: Professional Pharmacy Wholesale Services Inc, estimated spending by IT sub-segment ($m), 2008 84
Figure 33: Professional Pharmacy Wholesale Services Inc, estimated spending on IT by channel, 2008 86
Figure 34: Research methodology 88
LIST OF TABLES
Table 1: IT segments and sub segments 10
Table 2: Channel definitions 11
Table 3: Life sciences industry, Canada, estimated spending on IT ($m), 2008 and 2009 13
Table 4: Life sciences industry, Canada, estimated spending by technology segment ($m), 2008 15
Table 5: Life sciences industry, Canada, estimated spending on IT by channel ($m), 2008 17
Table 6: Extendicare REIT, IT budget estimates (%), 2008–09 18
Table 7: Extendicare REIT, IT budget by estimated entity (as % of overall IT budget), 2008 18
Table 8: Extendicare REIT, estimated spending by IT segment, 2008 20
Table 9: Extendicare REIT, estimated spending by IT sub-segment, 2008 22
Table 10: Extendicare REIT, estimated spending on IT by channel, 2008 24
Table 11: Biovail Corp, IT budget estimates (%), 2008–09 25
Table 12: Biovail Corp, estimated IT budget by entity (as % of overall IT budget), 2008 25
Table 13: Biovail Corp, estimated spending by IT segment, 2008 27
Table 14: Biovail Corp, estimated spending by IT sub-segment, 2008 29
Table 15: Biovail Corp, estimated spending on IT by channel, 2008 31
Table 16: MDS Inc, IT budget estimates (%), 2008–09 32
Table 17: MDS Inc, estimated IT budget by entity (as % of overall IT budget), 2008 32
Table 18: MDS Inc, estimated spending by IT segment, 2008 34
Table 19: MDS Inc, estimated spending by IT sub-segment, 2008 36
Table 20: MDS Inc, estimated spending on IT by channel, 2008 38
Table 21: Novartis Pharma Canada Inc, IT budget estimates (%), 2008–09 39
Table 22: Novartis Pharma Canada Inc, estimated IT budget by entity (as % of overall IT budget), 2008 39
Table 23: Novartis Pharma Canada Inc, estimated spending by IT segment, 2008 41
Table 24: Novartis Pharma Canada Inc, estimated spending by IT sub-segment, 2008 43
Table 25: Novartis Pharma Canada Inc, estimated spending on IT by channel, 2008 45
Table 26: Apotex Inc, IT budget estimates (%), 2008–09 46
Table 27: Apotex Inc, estimated IT budget by entity (as % of overall IT budget), 2008 46
Table 28: Apotex Inc, estimated spending by IT segment, 2008 48
Table 29: Apotex Inc, estimated spending by IT sub-segment, 2008 50
Table 30: Apotex Inc, estimated spending on IT by channel, 2008 52
Table 31: Angiotech Pharmaceuticals Inc, IT budget estimates (%), 2008–09 53
Table 32: Angiotech Pharmaceuticals Inc, estimated IT budget by entity (as % of overall IT budget), 2008 53
Table 33: Angiotech Pharmaceuticals Inc, estimated spending by IT segment, 2008 55
Table 34: Angiotech Pharmaceuticals Inc, estimated spending by IT sub-segment, 2008 57
Table 35: Angiotech Pharmaceuticals Inc, estimated spending on IT by channel, 2008 59
Table 36: Axcan Pharma Inc, IT budget estimates(%), 2008–09 60
Table 37: Axcan Pharma Inc, estimated IT budget by entity (as % of overall IT budget), 2008 60
Table 38: Axcan Pharma Inc, estimated spending by IT segment, 2008 62
Table 39: Axcan Pharma Inc, estimated spending by IT sub-segment, 2008 64
Table 40: Axcan Pharma Inc, estimated spending on IT by channel, 2008 66
Table 41: Aspreva Pharmaceuticals Corp, IT budget estimates (%), 2008–09 67
Table 42: Aspreva Pharmaceuticals Corp, estimated IT budget by entity (as % of overall IT budget), 2008 67
Table 43: Aspreva Pharmaceuticals Corp, estimated spending by IT segment, 2008 69
Table 44: Aspreva Pharmaceuticals Corp, estimated spending by IT sub-segment, 2008 71
Table 45: Aspreva Pharmaceuticals Corp, estimated spending on IT by channel, 2008 73
Table 46: Bayer Inc, IT budget estimates (%), 2008–09 74
Table 47: Bayer Inc, estimated IT budget by entity (as % of overall IT budget), 2008 74
Table 48: Bayer Inc, estimated spending by IT segment, 2008 76
Table 49: Bayer Inc, estimated spending by IT sub-segment, 2008 78
Table 50: Bayer Inc, estimated spending on IT by channel, 2008 80
Table 51: Professional Pharmacy Wholesale Services Inc, IT budget estimates (%), 2008–09 81
Table 52: Professional Pharmacy Wholesale Services Inc, estimated IT budget by entity (as % of overall IT budget), 2008 81
Table 53: Professional Pharmacy Wholesale Services Inc, estimated spending by IT segment, 2008 83
Table 54: Professional Pharmacy Wholesale Services Inc, estimated spending by IT sub-segment, 2008 85
Table 55: Professional Pharmacy Wholesale Services Inc, estimated spending on IT by channel, 2008 87
[Tabellenverzeichnis ausblenden]